Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis.

Jai Perumal,Roumen Balabanov,Laura Balcer,Steven Galetta,Zhaonan Sun, Hanyue Li,Danette Rutledge,Robin L Avila,Robert J Fox

Neurology and therapy（2023）

引用 0|浏览1

暂无评分

摘要

GOV: NCT01485003.

查看译文

关键词

African American,Cognitive processing speed,Hispanic,Natalizumab,No evidence of disease activity,Patient-reported outcome,Relapsing–remitting multiple sclerosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要